Integra LifeSciences Holdings (IART) — Free Cash Flow Generation Index
Integra LifeSciences Holdings (IART) has a Free Cash Flow Generation Index of -0.51x as of March 2026. Free cash flow of $-5.04 Million represents -1% of operating cash flow ($9.80 Million). Read Integra LifeSciences Holdings debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Integra LifeSciences Holdings Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Integra LifeSciences Holdings across 26 annual periods. Explore IART capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Integra LifeSciences Holdings (1999–2025)
Year-by-year Free Cash Flow Generation Index for Integra LifeSciences Holdings. For the full company profile including market capitalisation, see Integra LifeSciences Holdings market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | $-31.05 Million | $50.38 Million | $81.44 Million | ▼ -419.4% |
| 2024 | 0.19x | $24.96 Million | $129.38 Million | $104.42 Million | ▼ -63.1% |
| 2023 | 0.52x | $73.09 Million | $139.96 Million | $66.86 Million | ▼ -36.5% |
| 2022 | 0.82x | $217.38 Million | $264.47 Million | $47.09 Million | ▼ -2.9% |
| 2021 | 0.85x | $264.35 Million | $312.43 Million | $48.08 Million | ▲ +23.2% |
| 2020 | 0.69x | $139.94 Million | $203.83 Million | $63.89 Million | ▲ +64.0% |
| 2019 | 0.42x | $96.90 Million | $231.43 Million | $134.53 Million | ▼ -31.4% |
| 2018 | 0.61x | $121.94 Million | $199.68 Million | $77.74 Million | ▼ -1.5% |
| 2017 | 0.62x | $71.04 Million | $114.54 Million | $43.50 Million | ▲ +4.5% |
| 2016 | 0.59x | $69.08 Million | $116.41 Million | $47.33 Million | ▼ -8.2% |
| 2015 | 0.65x | $61.07 Million | $94.48 Million | $33.41 Million | ▲ +38.6% |
| 2014 | 0.47x | $37.07 Million | $79.46 Million | $42.40 Million | ▲ +358.7% |
| 2013 | 0.10x | $5.42 Million | $53.27 Million | $47.85 Million | ▲ +157.9% |
| 2012 | -0.18x | $-10.32 Million | $58.72 Million | $69.03 Million | ▼ -127.8% |
| 2011 | 0.63x | $65.90 Million | $104.33 Million | $38.42 Million | ▼ -2.5% |
| 2010 | 0.65x | $68.43 Million | $105.57 Million | $37.14 Million | ▼ -19.7% |
| 2009 | 0.81x | $115.67 Million | $143.24 Million | $27.57 Million | ▼ -1.0% |
| 2008 | 0.82x | $59.19 Million | $72.59 Million | $13.40 Million | ▲ +56.8% |
| 2007 | 0.52x | $24.45 Million | $47.03 Million | $22.57 Million | ▼ -38.0% |
| 2006 | 0.84x | $60.18 Million | $71.70 Million | $11.52 Million | ▼ -2.2% |
| 2005 | 0.86x | $48.80 Million | $56.85 Million | $8.05 Million | ▲ +9.8% |
| 2004 | 0.78x | $30.47 Million | $38.98 Million | $8.51 Million | ▼ -12.1% |
| 2003 | 0.89x | $30.98 Million | $34.83 Million | $3.84 Million | ▼ -4.3% |
| 2002 | 0.93x | $29.73 Million | $31.98 Million | $2.25 Million | ▲ +13.7% |
| 2001 | 0.82x | $12.84 Million | $15.70 Million | $2.86 Million | ▲ +113.8% |
| 1999 | -5.92x | $-14.80 Million | $2.50 Million | $17.30 Million | — |